Abstract: An ergonomic device is for a writing instrument. The ergonomic device includes a body having a first curved side, and a second curved side opposite to the first curved side and to be adjacent to the writing instrument. The ergonomic device also includes a first arm between the first curved side and the second curved side and extending outwardly from the body. The first arm defines a first opening to receive an index finger and a middle finger of a user. The ergonomic device includes a second arm between the first curved side and the second curved side and opposite to the first arm. The second arm extends outwardly from the body and defines a second opening to receive a thumb of the user.

Abstract: Systems, devices, and methods for pedestrian footfall counting are provided. The system includes a plurality of pedestrian footfall counting devices configured to capture and record optical data of pedestrians. The system further includes one or more relay servers configured to receive the optical data from the pedestrian footfall counting devices. The system further includes one or more counting servers configured to process the optical data and determine a pedestrian footfall count based on the optical data.

Abstract: A compact motion-activated light with flexible arm that enables a user to illuminate remote areas that would otherwise be difficult or impossible to illuminate. The device contains its own power source so that it does not need to be connected to an electrical outlet, enabling the user to place the device in areas where there are not electrical outlets or even no wired electricity such as basements, attics or garages.

Abstract: Catheter devices and methods are disclosed and described. A catheter device (100) can include a longitudinal lumen (104) and having a proximal end (104a) and a distal end (104b). The distal end (104b) is capable of insertion into at least the internal carotid artery. The catheter device (100) can include an occlusion balloon (120b) connected to the distal end (104b) and operable to occlude blood flow in a blood vessel (102) by inflation and deflation using a pressurization fluid. The catheter device (100) can include a pressure sensor (110b) associated with the distal end (104b) and operable to measure blood pressure data from at least one of a downstream (103b) and upstream (103a) location of the occlusion balloon (120b) and transmit the blood pressure data to a controller (150). The occlusion balloon (120b) can be operable to inflate or deflate based on inflation control information. The catheter device (100) can be used to treat cerebral thrombectomy in a subject.

Abstract: Systems, devices, and methods for pedestrian footfall counting are provided. The system includes a plurality of pedestrian footfall counting devices configured to capture and record optical data of pedestrians. The system further includes one or more relay servers configured to receive the optical data from the pedestrian footfall counting devices. The system further includes one or more counting servers configured to process the optical data and determine a pedestrian footfall count based on the optical data.

Abstract: Described herein is a method of coating a prosthetic device, such as an ocular prosthetic device, the method comprising nanoelectrospraying droplets comprising an active ingredient and/or a carrier species onto a surface of the prosthetic device in a predetermined pattern, the nanoelectrospraying involving controlling the flow rate of the droplets from a nozzle of the nanoelectrospraying equipment by controlling the voltage between the nozzle and the ocular prosthetic device. Also described herein are ocular prosthetic device formable according to the method.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: An external fluidic system and methods of operating the same are provided. The fluidic system can be hot-swap connected to a flow-cytometer-based system at runtime to expand sheath or waste fluid storage capability of the flow-cytometer-based system by making only minimal changes to the flow-cytometer-based system. The external fluidic system can include a pump and a controller configured to operate the external fluidic system such that the sheath fluid is supplied from the external fluidic system to the flow-cytometer-based system or the waste fluid is extracted from the flow-cytometer-teased system and provided to the external fluidic system.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: In some embodiments, systems, apparatuses and methods are described herein useful to indicate the number of products on a merchandising unit. Counting devices as described herein maintain an accurate count of the number of products on a given merchandising unit and provides a display of the count.

Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

Abstract: A compact motion-activated light with flexible arm that enables a user to illuminate remote areas that would otherwise be difficult or impossible to illuminate. The device contains its own power source so that it does not need to be connected to an electrical outlet, enabling the user to place the device in areas where there are not electrical outlets or even no wired electricity such as basements, attics or garages.